Clinical Trial Update: A Study to Assess the Potential for Airway Sensitivity Reactions With Propellants HFA-152a (Test) and HFA-134a (Reference) Administered Via Pressurized Inhalers in Adults With Mild Asthma [Phase 1]

View source ↗

Summary

A Phase 1 study sponsored by GlaxoSmithKline assessed potential airway sensitivity reactions to two inhaler propellants, HFA-152a (test) and HFA-134a (reference…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• HFA-134a (1,1,1,2-tetrafluoroethane)
• HFA-152a (1,1-difluoroethane)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 1 | Status: COMPLETED